Cargando…

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of novel coronavirus disease (COVID-19). Though vaccines and neutralizing monoclonal antibodies (mAbs) have been developed to fight COVID-19 in the past year, one major concern is the emergence of SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yue, Shuai, Li, Zhirong, Lin, Yao, Yang, Yang, Yuan, Mengqi, Pan, Zhiwei, Hu, Li, Gao, Leiqiong, Zhou, Jing, Tang, Jianfang, Wang, Yifei, Tian, Qin, Hao, Yaxing, Wang, Juan, Huang, Qizhao, Xu, Lifan, Zhu, Bo, Liu, Pinghuang, Deng, Kai, Wang, Li, Ye, Lilin, Chen, Xiangyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495157/ https://www.ncbi.nlm.nih.gov/pubmed/34630430 http://dx.doi.org/10.3389/fimmu.2021.751584

Ejemplares similares

Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial
por: Lin, Yao, et al.
Publicado: (2022)

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
por: Chen, Xiangyu, et al.
Publicado: (2020)

PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness
por: Chen, Xiangyu, et al.
Publicado: (2023)

Differential expression of inhibitory receptor NKG2A distinguishes disease‐specific exhausted CD8(+) T cells
por: Chen, Xiangyu, et al.
Publicado: (2022)

Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
por: Chen, Xiangyu, et al.
Publicado: (2020)

The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
por: Gao, Leiqiong, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD
por: Wang, Xiaofei, et al.
Publicado: (2022)

Molecular Basis of the Differentiation and Function of Virus Specific Follicular Helper CD4(+) T Cells
por: Huang, Qizhao, et al.
Publicado: (2019)

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
por: Yuan, Mengqi, et al.
Publicado: (2022)

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021)

NEUTRALIZATION TESTS WITH SERA OF CONVALESCENT OR IMMUNIZED ANIMALS AND THE VIRUSES OF SWINE AND HUMAN INFLUENZA
por: Francis, Thomas, et al.
Publicado: (1936)

The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection
por: Wang, Yifei, et al.
Publicado: (2019)

Immunoglobulin VH determinants defined by monoclonal antibodies
Publicado: (1982)

High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera
por: Astakhova, E. A., et al.
Publicado: (2022)

An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
por: Yuan, Mengqi, et al.
Publicado: (2023)

The Epigenetic Regulator EZH2 Instructs CD4 T Cell Response to Acute Viral Infection via Coupling of Cell Expansion and Metabolic Fitness
por: Li, Ren, et al.
Publicado: (2020)

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
por: Ding, Chengchao, et al.
Publicado: (2021)

The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection
por: Chen, Xiangyu, et al.
Publicado: (2019)

Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis
por: Li, Yiding, et al.
Publicado: (2020)

The Transcription Factor T-Bet Is Required for Optimal Type I Follicular Helper T Cell Maintenance During Acute Viral Infection
por: Wang, Pengcheng, et al.
Publicado: (2019)

The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines
por: Yang, Xinyi, et al.
Publicado: (2022)

Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
por: Zhang, Meng, et al.
Publicado: (2022)

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
por: Lusvarghi, Sabrina, et al.
Publicado: (2021)

Author Correction: Tumor-specific memory CD8(+) T cells are strictly resident in draining lymph nodes during tumorigenesis
por: Liu, Qiao, et al.
Publicado: (2023)

Tumor-specific memory CD8(+) T cells are strictly resident in draining lymph nodes during tumorigenesis
por: Liu, Qiao, et al.
Publicado: (2023)

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021)

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
por: Ma, Chengbao, et al.
Publicado: (2022)

Tumor-Specific CD4(+) T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4(–) T Cells
por: Liu, Qiao, et al.
Publicado: (2022)

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
por: Dupont, Liane, et al.
Publicado: (2021)

Development of an ELISA for distinguishing convalescent sera with Mycoplasma hyopneumoniae infection from hyperimmune sera responses to bacterin vaccination in pigs
por: Ding, Honglei, et al.
Publicado: (2021)

SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
por: Kuzmina, Alona, et al.
Publicado: (2021)

Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera
por: Kruglova, Natalia, et al.
Publicado: (2021)

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021)

Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera
por: Viriyakitkosol, Ratchanont, et al.
Publicado: (2023)

A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development
por: Li, Tuofan, et al.
Publicado: (2021)

Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong, Yunnan
por: Ma, Yingshuo, et al.
Publicado: (2021)

Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses
por: Srisutthisamphan, Kanjana, et al.
Publicado: (2022)

VH update
por: Arnold, Hannah
Publicado: (2022)

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
por: Chan, Kwok-Hung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_aus41rrauoqbhe30fgvl3sso08